Home > > > > > Report Detail

Global Calcium Channel Blocker Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Publisher Name :
Date: 19-Sep-2022
No. of pages: 116
Inquire Before Buying

Calcium channel blockers(CCBs) are medications which are used control high blood pressure, chest pain and arrhythmia. They are available through prescription and work by relaxing blood vessels and increase the blood and oxygen supply to the heart. This reduces the workload of the heart. It can be prescribed by itself or in combination with other medications to treat high blood pressure and angina. There are a few different types of CCB and each works in a slightly different way.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Calcium Channel Blocker market is projected to reach US$ 86 million by 2028 from an estimated US$ 78 million in 2022, at a CAGR of 1.6% during 2023 and 2028.

Global Calcium Channel Blocker key players include Pfizer, Aventis, Searle, Bayer, AstraZeneca, etc.

North America is the largest market, with a share about 30%, followed by Europe, and China, both have a share about 40 percent.

In terms of product, Amlodipine is the largest segment, with a share over 55%. And in terms of application, the largest application is Hypertension, followed by CHD, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Calcium Channel Blocker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Calcium Channel Blocker.

The Calcium Channel Blocker market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Calcium Channel Blocker market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Calcium Channel Blocker manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- Pfizer

- Aventis

- Searle

- Bayer

- AstraZeneca

- Knoll Pharmaceuticals

- Wyeth-Ayerst

- AstraZeneca

- Novartis

- Sanofi

Product Type Insights

Global markets are presented by Calcium Channel Blocker type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Calcium Channel Blocker are procured by the manufacturers.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Calcium Channel Blocker Segment by Type

- Dihydropyridine

- Diltiazem

- Verapamil

- Others

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Calcium Channel Blocker market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Calcium Channel Blocker market.

Calcium Channel Blocker Segment by Application

- Hypertension

- Coronary Artery Disease

- Arrhythmia

- Cardiomyopathy

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Calcium Channel Blocker market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Calcium Channel Blocker market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Calcium Channel Blocker and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Calcium Channel Blocker industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Calcium Channel Blocker

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution

Global Calcium Channel Blocker Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Calcium Channel Blocker Product Introduction
1.2 Market by Type
1.2.1 Global Calcium Channel Blocker Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Dihydropyridine
1.2.3 Diltiazem
1.2.4 Verapamil
1.2.5 Others
1.3 Market by Application
1.3.1 Global Calcium Channel Blocker Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Hypertension
1.3.3 Coronary Artery Disease
1.3.4 Arrhythmia
1.3.5 Cardiomyopathy
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Calcium Channel Blocker Market Size Estimates and Forecasts
2.1.1 Global Calcium Channel Blocker Revenue 2017-2028
2.1.2 Global Calcium Channel Blocker Sales 2017-2028
2.2 Calcium Channel Blocker Market Size by Region: 2022 Versus 2028
2.3 Calcium Channel Blocker Sales by Region (2017-2028)
2.3.1 Global Calcium Channel Blocker Sales by Region: 2017-2022
2.3.2 Global Calcium Channel Blocker Sales Forecast by Region (2023-2028)
2.3.3 Global Calcium Channel Blocker Sales Market Share by Region (2017-2028)
2.4 Calcium Channel Blocker Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Calcium Channel Blocker Revenue by Region: 2017-2022
2.4.2 Global Calcium Channel Blocker Revenue Forecast by Region (2023-2028)
2.4.3 Global Calcium Channel Blocker Revenue Market Share by Region (2017-2028)
3 Global Calcium Channel Blocker by Manufacturers
3.1 Global Top Calcium Channel Blocker Manufacturers by Sales
3.1.1 Global Calcium Channel Blocker Sales by Manufacturer (2017-2022)
3.1.2 Global Calcium Channel Blocker Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Calcium Channel Blocker Manufacturers by Revenue
3.2.1 Global Calcium Channel Blocker Revenue by Manufacturer (2017-2022)
3.2.2 Global Calcium Channel Blocker Revenue Share by Manufacturer (2017-2022)
3.3 Global Calcium Channel Blocker Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Calcium Channel Blocker Manufacturers Covered: Ranking by Revenue
3.4.2 Global Calcium Channel Blocker Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Calcium Channel Blocker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Calcium Channel Blocker Manufacturing Base Distribution, Product Type
3.5.1 Calcium Channel Blocker Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Calcium Channel Blocker Product Type
3.5.3 Date of International Manufacturers Enter into Calcium Channel Blocker Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Pfizer
4.1.1 Pfizer Corporation Information
4.1.2 Pfizer Description, Business Overview
4.1.3 Pfizer Calcium Channel Blocker Products Offered
4.1.4 Pfizer Calcium Channel Blocker Sales, Revenue and Gross Margin (2017-2022)
4.1.5 Pfizer Calcium Channel Blocker Sales by Product in 2021
4.1.6 Pfizer Calcium Channel Blocker Sales by Application in 2021
4.1.7 Pfizer Calcium Channel Blocker Sales by Geographic Area in 2021
4.1.8 Pfizer Recent Developments
4.2 Aventis
4.2.1 Aventis Corporation Information
4.2.2 Aventis Description, Business Overview
4.2.3 Aventis Calcium Channel Blocker Products Offered
4.2.4 Aventis Calcium Channel Blocker Sales, Revenue and Gross Margin (2017-2022)
4.2.5 Aventis Calcium Channel Blocker Sales by Product in 2021
4.2.6 Aventis Calcium Channel Blocker Sales by Application in 2021
4.2.7 Aventis Calcium Channel Blocker Sales by Geographic Area in 2021
4.2.8 Aventis Recent Developments
4.3 Searle
4.3.1 Searle Corporation Information
4.3.2 Searle Description, Business Overview
4.3.3 Searle Calcium Channel Blocker Products Offered
4.3.4 Searle Calcium Channel Blocker Sales, Revenue and Gross Margin (2017-2022)
4.3.5 Searle Calcium Channel Blocker Sales by Product in 2021
4.3.6 Searle Calcium Channel Blocker Sales by Application in 2021
4.3.7 Searle Calcium Channel Blocker Sales by Geographic Area in 2021
4.3.8 Searle Recent Developments
4.4 Bayer
4.4.1 Bayer Corporation Information
4.4.2 Bayer Description, Business Overview
4.4.3 Bayer Calcium Channel Blocker Products Offered
4.4.4 Bayer Calcium Channel Blocker Sales, Revenue and Gross Margin (2017-2022)
4.4.5 Bayer Calcium Channel Blocker Sales by Product in 2021
4.4.6 Bayer Calcium Channel Blocker Sales by Application in 2021
4.4.7 Bayer Calcium Channel Blocker Sales by Geographic Area in 2021
4.4.8 Bayer Recent Developments
4.5 AstraZeneca
4.5.1 AstraZeneca Corporation Information
4.5.2 AstraZeneca Description, Business Overview
4.5.3 AstraZeneca Calcium Channel Blocker Products Offered
4.5.4 AstraZeneca Calcium Channel Blocker Sales, Revenue and Gross Margin (2017-2022)
4.5.5 AstraZeneca Calcium Channel Blocker Sales by Product in 2021
4.5.6 AstraZeneca Calcium Channel Blocker Sales by Application in 2021
4.5.7 AstraZeneca Calcium Channel Blocker Sales by Geographic Area in 2021
4.5.8 AstraZeneca Recent Developments
4.6 Knoll Pharmaceuticals
4.6.1 Knoll Pharmaceuticals Corporation Information
4.6.2 Knoll Pharmaceuticals Description, Business Overview
4.6.3 Knoll Pharmaceuticals Calcium Channel Blocker Products Offered
4.6.4 Knoll Pharmaceuticals Calcium Channel Blocker Sales, Revenue and Gross Margin (2017-2022)
4.6.5 Knoll Pharmaceuticals Calcium Channel Blocker Sales by Product in 2021
4.6.6 Knoll Pharmaceuticals Calcium Channel Blocker Sales by Application in 2021
4.6.7 Knoll Pharmaceuticals Calcium Channel Blocker Sales by Geographic Area in 2021
4.6.8 Knoll Pharmaceuticals Recent Development
4.7 Wyeth-Ayerst
4.7.1 Wyeth-Ayerst Corporation Information
4.7.2 Wyeth-Ayerst Description, Business Overview
4.7.3 Wyeth-Ayerst Calcium Channel Blocker Products Offered
4.7.4 Wyeth-Ayerst Calcium Channel Blocker Sales, Revenue and Gross Margin (2017-2022)
4.7.5 Wyeth-Ayerst Calcium Channel Blocker Sales by Product in 2021
4.7.6 Wyeth-Ayerst Calcium Channel Blocker Sales by Application in 2021
4.7.7 Wyeth-Ayerst Calcium Channel Blocker Sales by Geographic Area in 2021
4.7.8 Wyeth-Ayerst Recent Development
4.8 AstraZeneca
4.8.1 AstraZeneca Corporation Information
4.8.2 AstraZeneca Description, Business Overview
4.8.3 AstraZeneca Calcium Channel Blocker Products Offered
4.8.4 AstraZeneca Calcium Channel Blocker Sales, Revenue and Gross Margin (2017-2022)
4.8.5 AstraZeneca Calcium Channel Blocker Sales by Product in 2021
4.8.6 AstraZeneca Calcium Channel Blocker Sales by Application in 2021
4.8.7 AstraZeneca Calcium Channel Blocker Sales by Geographic Area in 2021
4.8.8 AstraZeneca Recent Development
4.9 Novartis
4.9.1 Novartis Corporation Information
4.9.2 Novartis Description, Business Overview
4.9.3 Novartis Calcium Channel Blocker Products Offered
4.9.4 Novartis Calcium Channel Blocker Sales, Revenue and Gross Margin (2017-2022)
4.9.5 Novartis Calcium Channel Blocker Sales by Product in 2021
4.9.6 Novartis Calcium Channel Blocker Sales by Application in 2021
4.9.7 Novartis Calcium Channel Blocker Sales by Geographic Area in 2021
4.9.8 Novartis Recent Development
4.10 Sanofi
4.10.1 Sanofi Corporation Information
4.10.2 Sanofi Description, Business Overview
4.10.3 Sanofi Calcium Channel Blocker Products Offered
4.10.4 Sanofi Calcium Channel Blocker Sales, Revenue and Gross Margin (2017-2022)
4.10.5 Sanofi Calcium Channel Blocker Sales by Product in 2021
4.10.6 Sanofi Calcium Channel Blocker Sales by Application in 2021
4.10.7 Sanofi Calcium Channel Blocker Sales by Geographic Area in 2021
4.10.8 Sanofi Recent Development
5 Breakdown Data by Type
5.1 Global Calcium Channel Blocker Sales by Type (2017-2028)
5.1.1 Global Calcium Channel Blocker Sales by Type (2017-2022)
5.1.2 Global Calcium Channel Blocker Sales Forecast by Type (2023-2028)
5.1.3 Global Calcium Channel Blocker Sales Market Share by Type (2017-2028)
5.2 Global Calcium Channel Blocker Revenue Forecast by Type (2017-2028)
5.2.1 Global Calcium Channel Blocker Revenue by Type (2017-2022)
5.2.2 Global Calcium Channel Blocker Revenue Forecast by Type (2023-2028)
5.2.3 Global Calcium Channel Blocker Revenue Market Share by Type (2017-2028)
5.3 Calcium Channel Blocker Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Calcium Channel Blocker Sales by Application (2017-2028)
6.1.1 Global Calcium Channel Blocker Sales by Application (2017-2022)
6.1.2 Global Calcium Channel Blocker Sales Forecast by Application (2023-2028)
6.1.3 Global Calcium Channel Blocker Sales Market Share by Application (2017-2028)
6.2 Global Calcium Channel Blocker Revenue Forecast by Application (2017-2028)
6.2.1 Global Calcium Channel Blocker Revenue by Application (2017-2022)
6.2.2 Global Calcium Channel Blocker Revenue Forecast by Application (2023-2028)
6.2.3 Global Calcium Channel Blocker Revenue Market Share by Application (2017-2028)
6.3 Calcium Channel Blocker Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Calcium Channel Blocker Market Size YoY Growth 2017-2028
7.2 North America Calcium Channel Blocker Market Facts & Figures by Country
7.2.1 North America Calcium Channel Blocker Sales by Country (2017-2028)
7.2.2 North America Calcium Channel Blocker Revenue by Country (2017-2028)
7.3 North America Calcium Channel Blocker Sales by Type
7.4 North America Calcium Channel Blocker Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Calcium Channel Blocker Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Calcium Channel Blocker Market Facts & Figures by Region
8.2.1 Asia-Pacific Calcium Channel Blocker Sales by Region (2017-2028)
8.2.2 Asia-Pacific Calcium Channel Blocker Revenue by Region (2017-2028)
8.3 Asia-Pacific Calcium Channel Blocker Sales by Type
8.4 Asia-Pacific Calcium Channel Blocker Sales by Application
9 Europe
9.1 Europe Calcium Channel Blocker Market Size YoY Growth 2017-2028
9.2 Europe Calcium Channel Blocker Market Facts & Figures by Country
9.2.1 Europe Calcium Channel Blocker Sales by Country (2017-2028)
9.2.2 Europe Calcium Channel Blocker Revenue by Country (2017-2028)
9.3 Europe Calcium Channel Blocker Sales by Type
9.4 Europe Calcium Channel Blocker Sales by Application
10 Latin America
10.1 Latin America Calcium Channel Blocker Market Size YoY Growth 2017-2028
10.2 Latin America Calcium Channel Blocker Market Facts & Figures by Country
10.2.1 Latin America Calcium Channel Blocker Sales by Country (2017-2028)
10.2.2 Latin America Calcium Channel Blocker Revenue by Country (2017-2028)
10.3 Latin America Calcium Channel Blocker Sales by Type
10.4 Latin America Calcium Channel Blocker Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Calcium Channel Blocker Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Calcium Channel Blocker Market Facts & Figures by Country
11.2.1 Middle East and Africa Calcium Channel Blocker Sales by Country (2017-2028)
11.2.2 Middle East and Africa Calcium Channel Blocker Revenue by Country (2017-2028)
11.3 Middle East and Africa Calcium Channel Blocker Sales by Type
11.4 Middle East and Africa Calcium Channel Blocker Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Calcium Channel Blocker Supply Chain Analysis
12.2 Calcium Channel Blocker Key Raw Materials and Upstream Suppliers
12.3 Calcium Channel Blocker Clients Analysis
12.4 Calcium Channel Blocker Sales Channel and Sales Model Analysis
12.4.1 Calcium Channel Blocker Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Calcium Channel Blocker Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Calcium Channel Blocker Distributors
13 Market Dynamics
13.1 Calcium Channel Blocker Industry Trends
13.2 Calcium Channel Blocker Market Drivers
13.3 Calcium Channel Blocker Market Challenges
13.4 Calcium Channel Blocker Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Calcium Channel Blocker Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Manufacturers of Dihydropyridine
Table 3. Major Manufacturers of Diltiazem
Table 4. Major Manufacturers of Verapamil
Table 5. Major Manufacturers of Others
Table 6. Global Calcium Channel Blocker Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Calcium Channel Blocker Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
Table 8. Global Calcium Channel Blocker Sales by Region (2017-2022) & (Kg)
Table 9. Global Calcium Channel Blocker Sales Forecast by Region (2023-2028) & (Kg)
Table 10. Global Calcium Channel Blocker Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Calcium Channel Blocker Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 12. Global Calcium Channel Blocker Sales by Manufacturer (2017-2022) & (Kg)
Table 13. Global Calcium Channel Blocker Sales Share by Manufacturer (2017-2022)
Table 14. Calcium Channel Blocker Revenue by Manufacturer (2017-2022) & (US$ Million)
Table 15. Calcium Channel Blocker Revenue Share by Manufacturer (2017-2022)
Table 16. Key Manufacturers Calcium Channel Blocker Price (2017-2022) & (USD/g)
Table 17. Ranking of Global Top Calcium Channel Blocker Manufacturers by Revenue (US$ Million) in 2021
Table 18. Global Calcium Channel Blocker Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 19. Global Calcium Channel Blocker by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Calcium Channel Blocker as of 2021)
Table 20. Calcium Channel Blocker Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Calcium Channel Blocker Product Type
Table 22. Date of International Manufacturers Enter into Calcium Channel Blocker Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Pfizer Corporation Information
Table 25. Pfizer Description and Business Overview
Table 26. Pfizer Calcium Channel Blocker Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 27. Pfizer Calcium Channel Blocker Product
Table 28. Pfizer Calcium Channel Blocker Sales Proportion of Calcium Channel Blocker by Product in 2021
Table 29. Pfizer Calcium Channel Blocker Sales Proportion of Calcium Channel Blocker by Application in 2021
Table 30. Pfizer Calcium Channel Blocker Sales Proportion of Calcium Channel Blocker by Geographic Area in 2021
Table 31. Pfizer Recent Development
Table 32. Aventis Corporation Information
Table 33. Aventis Description and Business Overview
Table 34. Aventis Calcium Channel Blocker Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 35. Aventis Calcium Channel Blocker Product
Table 36. Aventis Calcium Channel Blocker Sales Proportion of Calcium Channel Blocker by Product in 2021
Table 37. Aventis Calcium Channel Blocker Sales Proportion of Calcium Channel Blocker by Application in 2021
Table 38. Aventis Calcium Channel Blocker Sales Proportion of Calcium Channel Blocker by Geographic Area in 2021
Table 39. Aventis Recent Development
Table 40. Searle Corporation Information
Table 41. Searle Description and Business Overview
Table 42. Searle Calcium Channel Blocker Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 43. Searle Calcium Channel Blocker Product
Table 44. Searle Calcium Channel Blocker Sales Proportion of Calcium Channel Blocker by Product in 2021
Table 45. Searle Calcium Channel Blocker Sales Proportion of Calcium Channel Blocker by Application in 2021
Table 46. Searle Calcium Channel Blocker Sales Proportion of Calcium Channel Blocker by Geographic Area in 2021
Table 47. Searle Recent Development
Table 48. Bayer Corporation Information
Table 49. Bayer Description and Business Overview
Table 50. Bayer Calcium Channel Blocker Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 51. Bayer Calcium Channel Blocker Product
Table 52. Bayer Calcium Channel Blocker Sales Proportion of Calcium Channel Blocker by Product in 2021
Table 53. Bayer Calcium Channel Blocker Sales Proportion of Calcium Channel Blocker by Application in 2021
Table 54. Bayer Calcium Channel Blocker Sales Proportion of Calcium Channel Blocker by Geographic Area in 2021
Table 55. Bayer Recent Development
Table 56. AstraZeneca Corporation Information
Table 57. AstraZeneca Description and Business Overview
Table 58. AstraZeneca Calcium Channel Blocker Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 59. AstraZeneca Calcium Channel Blocker Product
Table 60. AstraZeneca Calcium Channel Blocker Sales Proportion of Calcium Channel Blocker by Product in 2021
Table 61. AstraZeneca Calcium Channel Blocker Sales Proportion of Calcium Channel Blocker by Application in 2021
Table 62. AstraZeneca Calcium Channel Blocker Sales Proportion of Calcium Channel Blocker by Geographic Area in 2021
Table 63. AstraZeneca Recent Development
Table 64. Knoll Pharmaceuticals Corporation Information
Table 65. Knoll Pharmaceuticals Description and Business Overview
Table 66. Knoll Pharmaceuticals Calcium Channel Blocker Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 67. Knoll Pharmaceuticals Calcium Channel Blocker Product
Table 68. Knoll Pharmaceuticals Calcium Channel Blocker Sales Proportion of Calcium Channel Blocker by Product in 2021
Table 69. Knoll Pharmaceuticals Calcium Channel Blocker Sales Proportion of Calcium Channel Blocker by Application in 2021
Table 70. Knoll Pharmaceuticals Calcium Channel Blocker Sales Proportion of Calcium Channel Blocker by Geographic Area in 2021
Table 71. Wyeth-Ayerst Corporation Information
Table 72. Wyeth-Ayerst Description and Business Overview
Table 73. Wyeth-Ayerst Calcium Channel Blocker Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 74. Wyeth-Ayerst Calcium Channel Blocker Product
Table 75. Wyeth-Ayerst Calcium Channel Blocker Sales Proportion of Calcium Channel Blocker by Product in 2021
Table 76. Wyeth-Ayerst Calcium Channel Blocker Sales Proportion of Calcium Channel Blocker by Application in 2021
Table 77. Wyeth-Ayerst Calcium Channel Blocker Sales Proportion of Calcium Channel Blocker by Geographic Area in 2021
Table 78. AstraZeneca Corporation Information
Table 79. AstraZeneca Description and Business Overview
Table 80. AstraZeneca Calcium Channel Blocker Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 81. AstraZeneca Calcium Channel Blocker Product
Table 82. AstraZeneca Calcium Channel Blocker Sales Proportion of Calcium Channel Blocker by Product in 2021
Table 83. AstraZeneca Calcium Channel Blocker Sales Proportion of Calcium Channel Blocker by Application in 2021
Table 84. AstraZeneca Calcium Channel Blocker Sales Proportion of Calcium Channel Blocker by Geographic Area in 2021
Table 85. Novartis Corporation Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Calcium Channel Blocker Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 88. Novartis Calcium Channel Blocker Product
Table 89. Novartis Calcium Channel Blocker Sales Proportion of Calcium Channel Blocker by Product in 2021
Table 90. Novartis Calcium Channel Blocker Sales Proportion of Calcium Channel Blocker by Application in 2021
Table 91. Novartis Calcium Channel Blocker Sales Proportion of Calcium Channel Blocker by Geographic Area in 2021
Table 92. Sanofi Corporation Information
Table 93. Sanofi Description and Business Overview
Table 94. Sanofi Calcium Channel Blocker Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 95. Sanofi Calcium Channel Blocker Product
Table 96. Sanofi Calcium Channel Blocker Sales Proportion of Calcium Channel Blocker by Product in 2021
Table 97. Sanofi Calcium Channel Blocker Sales Proportion of Calcium Channel Blocker by Application in 2021
Table 98. Sanofi Calcium Channel Blocker Sales Proportion of Calcium Channel Blocker by Geographic Area in 2021
Table 99. Global Calcium Channel Blocker Sales by Type (2017-2022) & (Kg)
Table 100. Global Calcium Channel Blocker Sales Forecast by Type (2023-2028) & (Kg)
Table 101. Global Calcium Channel Blocker Revenue by Type (2017-2022) & (US$ Million)
Table 102. Global Calcium Channel Blocker Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 103. Global Calcium Channel Blocker Sales by Application (2017-2022) & (Kg)
Table 104. Global Calcium Channel Blocker Sales Forecast by Application (2023-2028) & (Kg)
Table 105. Global Calcium Channel Blocker Revenue by Application (2017-2022) & (US$ Million)
Table 106. Global Calcium Channel Blocker Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 107. North America Calcium Channel Blocker Sales by Country (2017-2022) & (Kg)
Table 108. North America Calcium Channel Blocker Sales by Country (2023-2028) & (Kg)
Table 109. North America Calcium Channel Blocker Revenue by Country (2017-2022) & (US$ Million)
Table 110. North America Calcium Channel Blocker Revenue by Country (2023-2028) & (US$ Million)
Table 111. North America Calcium Channel Blocker Sales by Type (2017-2022) & (Kg)
Table 112. North America Calcium Channel Blocker Sales by Application (2017-2022) & (Kg)
Table 113. Asia-Pacific Calcium Channel Blocker Sales by Region (2017-2022) & (Kg)
Table 114. Asia-Pacific Calcium Channel Blocker Sales by Region (2023-2028) & (Kg)
Table 115. Asia-Pacific Calcium Channel Blocker Revenue by Region (2017-2028) & (US$ Million)
Table 116. Asia-Pacific Calcium Channel Blocker Revenue by Region (2023-2028) & (US$ Million)
Table 117. Asia-Pacific Calcium Channel Blocker Sales by Type (2017-2022) & (Kg)
Table 118. Asia-Pacific Calcium Channel Blocker Sales by Application (2017-2022) & (Kg)
Table 119. Europe Calcium Channel Blocker Sales by Country (2017-2022) & (Kg)
Table 120. Europe Calcium Channel Blocker Sales by Country (2023-2028) & (Kg)
Table 121. Europe Calcium Channel Blocker Revenue by Country (2017-2022) & (US$ Million)
Table 122. Europe Calcium Channel Blocker Revenue by Country (2023-2028) & (US$ Million)
Table 123. Europe Calcium Channel Blocker Sales by Type (2017-2022) & (Kg)
Table 124. Europe Calcium Channel Blocker Sales by Application (2017-2022) & (Kg)
Table 125. Latin America Calcium Channel Blocker Sales by Country (2017-2022) & (Kg)
Table 126. Latin America Calcium Channel Blocker Sales by Country (2023-2028) & (Kg)
Table 127. Latin America Calcium Channel Blocker Revenue by Country (2017-2022) & (US$ Million)
Table 128. Latin America Calcium Channel Blocker Revenue by Country (2023-2028) & (US$ Million)
Table 129. Latin America Calcium Channel Blocker Sales by Type (2017-2022) & (Kg)
Table 130. Latin America Calcium Channel Blocker Sales by Application (2017-2022) & (Kg)
Table 131. Middle East and Africa Calcium Channel Blocker Sales by Country (2017-2022) & (Kg)
Table 132. Middle East and Africa Calcium Channel Blocker Sales by Country (2023-2028) & (Kg)
Table 133. Middle East and Africa Calcium Channel Blocker Revenue by Country (2017-2022) & (US$ Million)
Table 134. Middle East and Africa Calcium Channel Blocker Revenue by Country (2023-2028) & (US$ Million)
Table 135. Middle East and Africa Calcium Channel Blocker Sales by Type (2017-2022) & (Kg)
Table 136. Middle East and Africa Calcium Channel Blocker Sales by Application (2017-2022) & (Kg)
Table 137. Calcium Channel Blocker Key Raw Materials, Industry Status and Trend
Table 138. Calcium Channel Blocker Key Raw Materials and Upstream Suppliers
Table 139. Calcium Channel Blocker Clients Status and Trend
Table 140. Calcium Channel Blocker Typical Clients
Table 141. Calcium Channel Blocker Distributors
Table 142. Calcium Channel Blocker Market Trends
Table 143. Calcium Channel Blocker Market Drivers
Table 144. Calcium Channel Blocker Market Challenges
Table 145. Calcium Channel Blocker Market Restraints
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Calcium Channel Blocker Product Picture
Figure 2. Global Calcium Channel Blocker Sales Market Share by Type in 2021 & 2028
Figure 3. Dihydropyridine Product Picture
Figure 4. Diltiazem Product Picture
Figure 5. Verapamil Product Picture
Figure 6. Others Product Picture
Figure 7. Global Calcium Channel Blocker Sales Market Share by Application in 2021 & 2028
Figure 8. Hypertension Examples
Figure 9. Coronary Artery Disease Examples
Figure 10. Arrhythmia Examples
Figure 11. Cardiomyopathy Examples
Figure 12. Calcium Channel Blocker Report Years Considered
Figure 13. Global Calcium Channel Blocker Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Calcium Channel Blocker Market Size 2017-2028 (US$ Million)
Figure 15. Global Calcium Channel Blocker Sales 2017-2028 (Kg)
Figure 16. Global Calcium Channel Blocker Market Size Market Share by Region: 2022 Versus 2028
Figure 17. Global Calcium Channel Blocker Sales Market Share Forecast by Region (2017-2028)
Figure 18. Global Calcium Channel Blocker Revenue Market Share by Region (2017-2028)
Figure 19. Global Calcium Channel Blocker Sales Share by Manufacturer in 2021
Figure 20. Calcium Channel Blocker Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 21. Global Calcium Channel Blocker Sales Market Share Forecast by Type (2017-2028)
Figure 22. Global Calcium Channel Blocker Revenue Market Share Forecast by Type (2017-2028)
Figure 23. Calcium Channel Blocker Average Selling Price (ASP) by Type (2017-2022) & (USD/g)
Figure 24. Global Calcium Channel Blocker Sales Market Share Forecast by Application (2017-2028)
Figure 25. Global Calcium Channel Blocker Revenue Market Share Forecast by Application (2017-2028)
Figure 26. Calcium Channel Blocker Average Selling Price (ASP) by Application (2017-2022) & (USD/g)
Figure 27. North America Calcium Channel Blocker Revenue 2017-2028 (US$ Million)
Figure 28. North America Calcium Channel Blocker Sales Market Share by Type (2017-2022)
Figure 29. North America Calcium Channel Blocker Sales Market Share by Application (2017-2022)
Figure 30. Asia-Pacific Calcium Channel Blocker Revenue 2017-2028 (US$ Million)
Figure 31. Asia-Pacific Calcium Channel Blocker Sales Market Share by Region (2017-2028)
Figure 32. Asia-Pacific Calcium Channel Blocker Revenue Market Share by Region (2017-2028)
Figure 33. Asia-Pacific Calcium Channel Blocker Sales Market Share by Type (2017-2022)
Figure 34. Asia-Pacific Calcium Channel Blocker Sales Market Share by Application (2017-2022)
Figure 35. Europe Calcium Channel Blocker Revenue Growth Rate 2017-2028 (US$ Million)
Figure 36. Europe Calcium Channel Blocker Sales Market Share by Country (2017-2028)
Figure 37. Europe Calcium Channel Blocker Revenue Market Share by Country (2017-2028)
Figure 38. Europe Calcium Channel Blocker Sales Market Share by Type (2017-2022)
Figure 39. Europe Calcium Channel Blocker Sales Market Share by Application (2017-2022)
Figure 40. Latin America Calcium Channel Blocker Revenue Growth Rate 2017-2028 (US$ Million)
Figure 41. Latin America Calcium Channel Blocker Sales Market Share by Country (2017-2028)
Figure 42. Latin America Calcium Channel Blocker Revenue Market Share by Country (2017-2022)
Figure 43. Latin America Calcium Channel Blocker Sales Market Share by Type (2017-2022)
Figure 44. Latin America Calcium Channel Blocker Sales Market Share by Application (2017-2022)
Figure 45. Middle East and Africa Calcium Channel Blocker Revenue Growth Rate 2017-2028 (US$ Million)
Figure 46. Middle East and Africa Calcium Channel Blocker Sales Market Share by Country (2017-2028)
Figure 47. Middle East and Africa Calcium Channel Blocker Revenue Market Share by Country (2017-2028)
Figure 48. Middle East and Africa Calcium Channel Blocker Sales Market Share by Type (2017-2022)
Figure 49. Middle East and Africa Calcium Channel Blocker Sales Market Share by Application (2017-2022)
Figure 50. Calcium Channel Blocker Supply Chain (Upstream and Downstream Market)
Figure 51. Global Production Market Share of Calcium Channel Blocker Raw Materials by Region in 2021
Figure 52. Calcium Channel Blocker Distribution Channels
Figure 53. Global Calcium Channel Blocker Percentage 2017-2028: Indirect Sales VS Direct Sales
Figure 54. Global Calcium Channel Blocker Percentage 2017-2028: Online Sales VS Offline Sales
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
  • Global Pulmonary Arterial Hypertension (Pah) Medicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Pulmonary Arterial Hypertension (Pah) Medicine market: According to our latest research, the global Pulmonary Arterial Hypertension (Pah) Medicine market looks promising in the next 5 years. As of 2022, the global Pulmonary Arterial Hypertension (Pah) Medicine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to ......
  • Global Nifedipine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 102
    Market Overview of Global Nifedipine market: According to our latest research, the global Nifedipine market looks promising in the next 5 years. As of 2022, the global Nifedipine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nifedipine market, with a systematical de......
  • Global Amlodipine Besylate Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 115
    The Amlodipine Besylate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profil......
  • Pulmonary Arterial Hypertension (PAH) Drugs - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 112
    The global Pulmonary Arterial Hypertension (PAH) Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pulmonary Arterial Hypertension (PAH) Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Other,, are propelling Pulmonary Arterial Hypertension (PAH) Drugs market. Inhalation, one of the segments analysed in this report, is projected to record % ......
  • Captopril API - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 100
    The global Captopril API market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Captopril API in various end use industries. The expanding demands from the Captopril Tablet, Compound Captopril Tablet and Captopril Injection,, are propelling Captopril API market. 98% Captopril API, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......
  • Telmisartan - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 107
    The global Telmisartan market size is expected to reach US$ 3631.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Telmisartan in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Telmisartan market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-Dried......
  • Global Ambrisentan Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 106
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Ambrisentan Market Research Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 132
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Amlodipine Besylate Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 133
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs